New cell therapy aims to prevent painful mouth sores in stem cell transplants
NCT ID NCT07400328
First seen Feb 14, 2026 · Last updated May 13, 2026 · Updated 8 times
Summary
This study tests whether a single infusion of amimestrocel, a cell therapy made from human umbilical cord cells, can prevent severe mouth and gut sores in patients receiving a stem cell transplant. About 22 adults will receive the infusion 1-2 days before their transplant. Researchers will monitor for mouth sores, pain, and side effects for 28 days, with safety follow-up for 100 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
First Affiliated Hospital of Soochow University
RECRUITINGSuzhu, Jiangsu, 215006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.